Clinical Trial Update: Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 trial update on pirfenidone for restrictive chronic lung allograft dysfunction in lung transplant patients; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Transplant Rejection
• Restrictive Chronic Lung Allograft Dysfunction

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: University of California, San Francisco | Conditions: Restrictive Chronic Lung Allograft Dysfunction, Lung Transplant Rejection | Phase 2 | Status: COMPLETED | Results posted: 2023-01-09